Celldex shareholders elect all director nominees, ratify auditor, approve executive compensation at 2022 annual meeting

Celldex Therapeutics, Inc.

All 8 director nominees elected; Karen L. Shoos received 39.9M votes for, 1.0M withheld.
Ratification of PricewaterhouseCoopers as auditor for FY2022 approved with 43.3M votes for.
Advisory say-on-pay approved: 40.0M for, 717k against, 180k abstain.
Broker non-votes of 2.5M shares on director election and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.